Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol.

Sec. Antibiotic Resistance and New Antimicrobial drugs

Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1678719

Clonal transmission and species-specific mechanisms of polymyxin resistance in carbapenem-resistant Enterobacteriaceae from Southwest China

Provisionally accepted
Tingting  SiTingting Si1Hang  LiuHang Liu2Peiwen  XiaPeiwen Xia1Na  HuangNa Huang1Shiyu  TangShiyu Tang1Yuqiong  LiYuqiong Li1Qi  HanQi Han1Yuanyuan  SongYuanyuan Song1Yingyi  LiuYingyi Liu1Yun  XiaYun Xia1*
  • 1The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
  • 2Department of Clinical Laboratory, Institute of Translational Medicine, Renmin Hospital of Wuhan University, Wuhan, China

The final, formatted version of the article will be published soon.

Objectives: The rapid dissemination of carbapenem-resistant Enterobacteriaceae (CRE) poses a severe global health threat due to limited treatment options. Polymyxin is currently considered a last-resort therapy for human infections caused by CRE. The increasing clinical use of polymyxin has resulted in alarming resistance rates. This study investigated the clinical characteristics, molecular epidemiological characteristics, and resistance mechanisms of polymyxin-resistant CRE (PR-CRE) in Chongqing, China. Methods: Antimicrobial susceptibility and resistance genes were analyzed by PCR-based amplification and sequence analysis. Molecular epidemiological characteristics were analyzed using Enterobacterial Repetitive Intergenic Consensus (ERIC)-PCR and multilocus sequence typing (MLST). The gene expression of pmrC and pmrK was analyzed using qRT-PCR. Conjugation experiments were performed to determine plasmid transferability. Whole-genome sequencing (WGS) was performed to analyze their genetic environment. Results: Thirty PR-CRE isolates, including 21 Klebsiella pneumoniae and 9 Escherichia coli, exhibited multidrug resistance, with three pan-resistant K. pneumoniae strains. The predominant lineage was ST11-K64 K. pneumoniae (n=14/21), with four genetically identical isolates from ICUs, confirming clonal transmission. In contrast, all E. coli displayed high genetic diversity. Hypervirulence determinants were detected in 38.1% (n=8/21) of K. pneumoniae. Two rare K. pneumoniae strains were identified: one hypervirulent ST3984-KL64 strain co-harboring blaKPC-2 and blaNDM-1, and one ST2383-KL81 strain harboring blaOXA-48. Species-specific resistance mechanisms emerged: K. pneumoniae relied on chromosomal mutations in mgrB, phoPQ, and pmrAB, especially mgrB inactivation (57.1%, n=12/21) via ISKpn26/IS903B/ ISAeme19/ISKpn14 and pmrK upregulation (95.2%, n=20/21), while E. coli exclusively used plasmid-borne mcr-1 with 55.6% (n=5/9) conjugation efficiency, conferring low-level resistance. Genomic sequencing revealed that four identical ISAeme19 copies were first identified in ST11-KL64 hypervirulent CRKP-5: two on the chromosome (mgrB and kdsD), and two on plasmids (IncFII/IncR pkp2007-KPC and recombinant pkp2007-D). Transposition of ISAeme19 from pkp2007-KPC to mgrB was evidenced by the inverted orientation and matching flanking repeats. Crucially, a pan-resistant ST11-KL64 K. pneumoniae harbored a fusion plasmid with dual blaKPC-2 and catA2 copies bracketed by IS26, a previously unreported configuration. Additionally, four novel deleterious mutations were detected: mgrB-Asn25Thr, phoP-Lys199Met, phoQ-Tyr89His, and RamR-Ala17Thr. Conclusion: These findings reveal species-divergent resistance mechanisms to polymyxin, necessitating enhanced surveillance of these high-risk clones, mobile elements, and emergent resistance mechanisms.

Keywords: Carbapenem-resistant Enterobacteriaceae, polymyxin resistance, mgrB inactivation, MCR-1, fusion plasmid, clonal transmission

Received: 03 Aug 2025; Accepted: 29 Sep 2025.

Copyright: © 2025 Si, Liu, Xia, Huang, Tang, Li, Han, Song, Liu and Xia. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Yun Xia, xiayun12cn@aliyun.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.